NCT07468708 2026-03-12
The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate Cancer
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
Clinical Trials
12 trialsNCT06645808 2025-12-29
VARTUTRACE
Var2 Pharmaceuticals
Phase EARLY_PHASE1 Recruiting
NCT06516510 2025-09-25
A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer
Blue Earth Therapeutics Ltd
Phase EARLY_PHASE1 Terminated
NCT04726033 2024-05-01
CUPID
Telix Pharmaceuticals (Innovations) Pty Limited
Phase EARLY_PHASE1 Completed
NCT05725070 2023-10-06
Phase 0/1 Study of 212Pb-NG001 in mCRPC
ARTBIO Inc.
Phase EARLY_PHASE1 Completed
NCT04116164 2023-09-25
Safety and Targeting of Anti-hk2 Antibody in mCRPC
SpectronRX
Phase EARLY_PHASE1 Terminated
NCT01253213 2023-08-01
BR55 in Prostate Cancer: an Exploratory Clinical Trial
Bracco Diagnostics, Inc
Phase EARLY_PHASE1 Completed
NCT02826382 2023-01-12
Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041
Five Eleven Pharma, Inc.
Phase EARLY_PHASE1 Completed
NCT05395260 2022-08-19
FL- 101 Study in Non-Metastatic MIBC
Flame Biosciences
Phase EARLY_PHASE1 Withdrawn
NCT03692663 2022-08-01
Study of Anti-PSMA CAR NK Cell (TABP EIC) in Metastatic Castration-Resistant Prostate Cancer
Allife Medical Science and Technology Co., Ltd.
Phase EARLY_PHASE1 Unknown
NCT03454243 2019-04-25
TITAN
Hoffmann-La Roche
Phase EARLY_PHASE1 Terminated
NCT00884520 2010-03-16
VM4-037
Siemens Molecular Imaging
Phase EARLY_PHASE1 Completed